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Background. Remodeling is an important long-term determinant of cardiac function 2 
throughout the progression of heart disease. Numerous biomolecular pathways for 3 
mechanosensing and transduction are involved. However, we hypothesize that biomechanical 4 
factors alone can explain changes in myocardial volume and chamber size in valve disease. 5 
Methods. A validated model of the human vasculature and the four cardiac chambers was used 6 
to simulate aortic stenosis, mitral regurgitation and aortic regurgitation. Remodeling was 7 
simulated with adaptive feedback preserving myocardial fiber stress and wall shear stress in all 8 
four cardiac chambers. Briefly, the model used myocardial fiber stress to determine wall 9 
thickness and cardiac chamber wall shear stress to determine chamber volume. 10 
Results. Aortic stenosis resulted in the development of concentric left ventricular hypertrophy. 11 
Aortic and mitral regurgitation resulted in eccentric remodeling and eccentric hypertrophy, with 12 
more pronounced hypertrophy for aortic regurgitation. Comparisons with published clinical 13 
data showed the same direction and similar magnitudes of changes in end-diastolic volume 14 
index and left ventricular diameters. Changes in myocardial wall volume and wall thickness 15 
were within a realistic range both in stenotic and regurgitant valvular disease.  16 
Conclusions. Simulations of remodeling in left-sided valvular disease support, in both a 17 
qualitative and quantitative manner, that left ventricular chamber size and hypertrophy are 18 
primarily determined by preservation of wall shear stress and myocardial fiber stress.  19 
 20 
Key words: Cardiac remodeling, Hypertrophy, Valvular disease, Wall shear stress, Myofiber 21 
stress, Simulations  22 
 23 
New	&	Noteworthy		24 
Cardiovascular simulations with adaptive feedback that normalizes wall shear stress and fiber 25 
stress in the cardiac chambers could predict – in a quantitative and qualitative manner – 26 
remodeling patterns seen in patients with left-sided valvular disease. This highlights how 27 
mechanical stress remains a fundamental aspect of cardiac remodeling. This in silico study 28 
validated with clinical data paves the way for future patient-specific predictions of remodeling 29 




The concept of cardiac remodeling was originally coined to describe structural changes in the 32 
left ventricle after myocardial infarction, and is currently used in a broader context, referring to 33 
the heart’s plasticity in general (5, 9, 20). Over the last decades, it has been considered of 34 
paramount importance to understand cardiac disease processes that manifest as changes in size, 35 
shape, structure and function of the myocardium. The remodeling process has been viewed both 36 
as a beneficial, adaptive response that counteracts the negative effects of disease (40) and as 37 
detrimental maladaptation causing organ failure and death (9, 12, 23, 49). One of the primary 38 
elements in cardiac remodeling is the response to biomechanical stresses (38), although 39 
neurohumoral factors, ion channels and cell-cell interactions may also contribute to intracellular 40 
signaling cascades that ultimately result in altered myocardial composition and cellular changes 41 
(20).  42 
The cardiomyocyte has the capability to elongate by adding new sarcomeres in series as well 43 
as to increase its radius by adding sarcomeres in parallel as a response to mechanical stress (48). 44 
Left ventricular hypertrophy is a primary element of this structural remodeling process, and 45 
occurs both due to cellular growth and alterations of the extracellular matrix (9, 12, 40). 46 
Advances in cardiac magnetic resonance imaging now allow to measure and distinguish 47 
between cellular and matrix volume, and a recent study has shown that most cases of 48 
pathological ventricular hypertrophy result from a proportional increase in both cellular and 49 
matrix components (46).  50 
In order to unravel the nature of the cardiac phenotype, simulations of hemodynamics based on 51 
established and validated physical laws are powerful tools to test mechanistic hypotheses within 52 
the cardiovascular system. The main driving mechanisms of mechanical adaptation to changing 53 
loading conditions need to be identified. So far, it has been postulated, that fiber stress (σf) plays 54 
an important role in cardiac remodeling and in particular as a determinant of wall thickness 55 
(18). Additionally, increased wall shear stress (σwss) has been suggested to cause vessel dilation 56 
in vascular remodeling (24, 36, 50), and we propose that it has a comparable effect in cardiac 57 
remodeling, where volume loading (increasing σwss) is known to cause dilatation in a way 58 
similar to vessel dilatation in response to increasing flow (26, 43). σwss can be described as the 59 
tangential frictional force between blood flow and the endothelium/endocardium. Based on 60 
these considerations, we hypothesize that preserving mean σf and mean σwss are the major 61 
biomechanical drivers of cardiac remodeling. Specifically, we assume σwss to be the major 62 
determinant of chamber size and σf the major factor responsible for changes in wall thickness 63 
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and myocardial volume. The aim of this study was to assess the validity of these hypotheses by 64 
comparing computer simulations with clinical imaging data in the three most common valve 65 
diseases (11, 28), i.e. in aortic stenosis, mitral regurgitation and aortic regurgitation, where early 66 
detection and appropriate timing of surgical intervention are of great clinical importance (21, 67 
28). 68 
Methods	69 
A closed-loop real-time cardiovascular simulation model of the cardiovascular system 70 
previously developed and validated was used as simulation platform for this study (7, 8, 13). 71 
The model was expanded to include real-time calculations of σf and σwss to allow the 72 
implementation of adaptive remodeling rules.  73 
 74 
Modeling	assumptions	75 
The following sections explain the geometrical assumptions made for the four cardiac chambers 76 
and the two adaptation rules implemented to simulate the cardiac remodeling process.  77 
 78 
Chambers’	geometry	79 
Cardiac chambers’ geometry was approximated with simple geometric shapes. The atria were 80 
both considered as spheres, the left ventricle as a half ellipsoid and the right ventricle as a 81 
quarter of an ellipsoid (Figure 1). Throughout the text, all parameters and variables that change 82 
with time are indicated with lower-case letters, whereas constant parameters are indicated with 83 
upper-case letters. All chambers were characterized by an inner radius r and a wall thickness h. 84 
The length of the ventricular ellipsoidal shapes was set to 3r, based on clinical data (45). No 85 
interatrial nor interventricular septal interactions were taken into account. Based on these 86 
assumptions, wall and chamber volumes were calculated as follows. Equations (1) and (2) 87 
represent the atrial cavity volume and the atrial myocardial wall volume, respectively. 88 
Similarly, equation (3) and (4) represent the left ventricular (LV) cavity volume and the LV 89 
myocardial wall volume. The volume of the right ventricular (RV) cavity and RV wall volume 90 






Figure 1. (A) Atria. Both the left and right atrium are approximated to be spheres with an 
inner radius of r, a wall thickness of h, an inner blood volume of v and a wall volume of vwall. 
(B) Left ventricle. The left ventricle is approximated to be a half ellipsoid with max inner 
radius r, wall thickness h and a length of 3r. (C) Right ventricle. The right ventricle is 
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Instantaneous σf was calculated as indicated in equation 5, based on previous work by Arts et 93 
al (1). Myocardial σwss was calculated assuming a laminar flow through a tube with the same 94 
diameter as the largest chamber diameter (equation 6), analogous to vascular tissue remodeling 95 
(35). Chamber flow qchamber was calculated as the mean value of absolute inlet and outlet flows 96 
at each time step in the simulation, as shown in equation 7. In such a way, σwss is affected by 97 
both antegrade and retrograde flow. If no regurgitant valve flows or shunts are present, then 98 
mean qchamber equals cardiac output. In regurgitant valve disease, qchamber becomes considerably 99 
larger than cardiac output because the absolute value of both forward and backward flows are 100 
taken into account. 101 
 102 
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Variables and constants. sf = chamber myofiber stress, p = chamber intracavitary pressure, ln = 103 
natural logarithm operator, vwall = chamber wall volume, vlumen = chamber intracavitary blood 104 
volume, σwss = chamber wall shear stress, h = blood viscosity, qchamber = chamber blood flow,  105 
r = chamber radius, qinlet = inlet valve blood flow, qoutlet = outlet valve blood flow.  106 
	107 
Myocardial	volume	adaptation	108 
The first remodeling rule determines the adaption of myocardial wall volume by preservation 109 
of sf. Total myocardial volume was assumed to be 160 mL based on a generic adult person of 110 
70 kg and 170 cm length with a body surface area of 1.81 m2. We assumed that the myocardium 111 
was distributed among the four cardiac chambers in proportion to the sum of the passive 112 
stiffness constant and the systolic contractility (see Appendix for further details). Then, 113 
7 
 
remodeling rules were activated, and parameters reached the values presented in Table 1. This 114 
set of parameters was the starting point of the valve disease simulations. 115 
 116 
Table 1. Start values representing normal physiology at mean wall shear stress 0.0025 mmHg 117 
and mean myofiber stress 120 mmHg in all chambers. Gray columns show baseline elastance 118 
values and white columns chamber dimensions derived from elastance values using the 119 
geometric assumptions and remodeling algorithms described in the main text.   120 












 mmHg/mL mmHg/mL mmHg/mL mL mm mm 
RA 0.097 0.065 0.162 6 48* 0.9* 
RV 0.012 0.599 0.611 24 68/50** 2.7/4.5** 
LA 0.144 0.103 0.247 10 47* 1.3* 
LV 0.021 2.735 2.753 108 54/39** 8.2/12.8** 
TOTAL 0.274 3.502 3.776 148   
RA = right atrium, RV = right ventricle, LA = left atrium, LV= Left ventricle. 121 
*mean value, **end-diastolic/end-systolic. 122 
 123 
The target σf was set to 120 mmHg in each cardiac chamber. This value was chosen as it 124 
provided physiological arterial pressure and cardiac output. The wall volume was assumed 125 
proportional to the total elastance and adjusted until the target σf was reached. The total 126 
myocardial volume was updated accordingly. Both stiffness constant and contractility were 127 
changed proportionally (see appendix for definitions and further details). This means that an 128 
increase in contractility was assumed to be accompanied by an increase in passive stiffness as 129 
is seen in many patients with clinical LV hypertrophy due to structural valve disease or 130 
hypertension (30, 42, 51). 131 
 132 
Chamber	volume	adaptation	133 
The second remodeling rule determines the adaption of chamber volume in order to preserve 134 
σwss, with a target value of 0.0025 mmHg (see Appendix for target value selection criteria and 135 
sensitivity). The adaptation operates as follows: σwss is continuously calculated during 136 
simulations as in equation 2. Then, the volume intercept V0 of the elastance function of each 137 
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chamber is adjusted until a target σwss value of 0.0025 mmHg is reached. A change in V0 can 138 
be interpreted as a change in the unstressed chamber volume by adding/removing or 139 
elongating/shortening sarcomeres in series within the cardiomyocyte.  140 
The two rules act simultaneously and myocardial σf and σwss interact mutually because (i) they 141 
are both affected by changes in chamber size and (ii) the wall volume and the chamber volume 142 
are both determinants of stress. In general, dilatation of a chamber will lead to an increase in σf, 143 
which in turn requires an increase in wall volume and wall thickness to preserve σf .  144 
 145 
Simulation	of	valvular	disease	146 
Aortic stenosis was simulated by incrementally decreasing the open aortic valve area from 5.0 147 
cm2 to 0.5 cm2 in steps of 1.00 cm2 for the mild range and steps of 0.25 cm2 for the severe 148 
range. Mitral regurgitation was simulated by increasing the closed mitral valve area from 0.0 149 
cm2 to 0.80 cm2 in steps of 0.10 cm2, corresponding to regurgitant fractions from 0% to 54%. 150 
Aortic regurgitation was simulated by increasing the closed aortic valve area from 0.0 cm2 to 151 
0.45 cm2 in steps of 0.05 cm2, corresponding to a regurgitant fraction increase from 0% to 61%. 152 
Heart rate, vascular properties and blood volume were kept unchanged. Consequently, no 153 
autoregulatory or compensatory mechanisms were included in the simulations, other than 154 
cardiac remodeling. The pericardium was allowed to remodel in size (41) to create a mean 155 
pericardial pressure of 0 mmHg – therefore the pericardium did not constrain the heart. Notably, 156 
vascular properties were kept unchanged in the simulation study. In this way, possible 157 
confounding factors were limited, increasing the correlation between the regurgitant/stenotic 158 
valve area and degree of remodeling.  159 
Additionally, the independent effect of σwss and σf adaptation was tested by simulating various 160 
degrees of aortic regurgitation while preserving only one variable at the time. First, σwss 161 
adaptation was allowed, but not σf, and then vice versa.  162 
 163 
Calculations	164 
Simulations were run using the software Aplysia CardioVascular Lab 7.0.4.11 (Aplysia 165 
Medical AB, Stockholm, Sweden). Mean values in the model were calculated as a weighted 166 
running average with recent values having more impact than older ones (see appendix for 167 
details). Intrathoracic pressure changes due to respiration were omitted in the simulations. 168 
Hemodynamic differential equations were solved with implicit or explicit Euler’s method, 169 
while wall thickness 3rd degree polynomial equations were solved with Newton-Raphson’s 170 
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method. Pressures, flows, volumes and saturations in every compartment were calculated with 171 
a frequency of 4000 Hz. Calculations and adaptation of σf and σwss algorithms were 172 
implemented in the software and run automatically, reaching stable steady-state values within 173 
5 minutes. This implies that acute hemodynamics were simulated in real-time, but remodeling 174 
was simulated in a time-scale at least 10,000 times faster than in real physiology (50,000 175 
minutes corresponding to 35 days). All data were collected at end-diastole when simulations 176 
had reached a steady-state regarding remodeling, hemodynamics and oxygen transport. 177 
 178 
Comparison	with	clinical	data	179 
Simulation results were compared with published clinical data on LV mass and volume for 180 
aortic stenosis (14) and mitral and aortic regurgitation (47). Specifically, the data were extracted 181 
from Uretsky et al. (47) by calculating the desired variable y using the regression equation 182 
reported in the reference, with x equal to the simulated regurgitant flow. Simulation outputs 183 
were then compared with patients´ values in a quantitative manner by looking at the slope and 184 
offset of the linear regression lines. When such data were not available in the reference studies 185 
(14, 47), a qualitative comparison of remodeling patterns in simulations and patients was 186 
performed. The different LV remodeling patterns were classified as follows (i) concentric 187 
remodeling: LV diameter preserved or reduced with wall volume increase below clinical 188 
detection limit of current imaging techniques; (ii) concentric hypertrophy: LV diameter 189 
preserved or reduced with increase in wall volume; (iii) eccentric remodeling: LV diameter 190 
increased in size with wall volume increase below clinical detection limit; (iv) eccentric 191 
hypertrophy: LV diameter increased with increase in wall volume.  192 
Results	193 
Simulation output for the three different valvular diseases are shown in Figure 2 and are 194 
described in the following sections including a quantitative comparison with published clinical 195 
data. Figure 2 shows a summary of the simulation for the three valvular diseases investigated. 196 
The regurgitant/stenotic valve area is reported as a label at each simulated step. Aortic stenosis 197 
showed a concentric remodeling pattern (decrease in LV end-diastolic volume) accompanied 198 
by large increase in LV wall volume, especially for the most severe cases. On the contrary, 199 
aortic and mitral regurgitation show an eccentric remodeling pattern with increased LV end-200 
diastolic volume. Aortic regurgitation showed a more pronounced hypertrophy (increase in LV 201 
wall volume) than mitral regurgitation. Additional hemodynamic outputs are presented in Table 202 




Figure 2. Simulation output of changes in left ventricular end-diastolic volumes and wall 
volumes in valvular disease with varying valve areas. Aortic stenosis (AS), mitral 
regurgitation (MR) and aortic regurgitation (AR). Valve areas for each simulation step are 
indicated in the figure. AS result in concentric hypertrophy and AR and MR in eccentric 
hypertrophy (more pronounced hypertrophy in AR). 
	204 
Aortic	stenosis	205 
Simulations of aortic stenosis with adaptive remodeling showed that systolic arterial pressure 206 
and cardiac output at rest were preserved until the aortic valve area reached approximately 207 
1.5 cm2. For smaller areas, systolic pressure dropped from 118 mmHg to 105 mmHg in the 208 
most severe case, with a maximum aortic valve area of 0.5 cm2, and cardiac output changing 209 
from 5.7 L/min to 5.1 L/min. Diastolic arterial pressure was essentially preserved. Resulting 210 
LV geometries are shown in Figure 3. The LV hypertrophied for aortic areas below 1.5 cm2. 211 
LV diastolic wall thickness increased from 10.7 mm to 28.0 mm when the aortic valve area 212 
decreased between 1.5 cm2 and 0.5 cm2. At the same time, the LV preserved its diameter until 213 
valve areas fell below 1.0 cm2 and slightly decreased in the most severe case. The LA preserved 214 
its size. The results suggest that a normal LV internal diameter is preserved down to an aortic 215 
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valve area of approximately 2 cm2. For more severe stenosis, the LV showed a concentric 216 
remodeling pattern down to a valve area of 1.5 cm2. For the most severe stenosis areas, the LV 217 
geometry can be classified as concentric hypertrophy. Simulation output are in agreement with 218 
data from patients with aortic stenosis (18), although patients in the study by Dweck et al. (14) 219 
exhibited different LV remodeling patterns: normal LV, concentric remodeling and concentric 220 
hypertrophy, both symmetric and asymmetric.  221 
 
Figure 3. Simulation output of different degrees of severity of aortic stenosis with myocardial 
remodeling. A small aortic opening area results in a large increase in systolic and diastolic 






Simulations of mitral regurgitation with adaptive remodeling showed that systemic arterial 225 
blood pressure decreased from 122/76 (systolic/diastolic) mmHg with no regurgitant volume to 226 
100/63 mmHg in the most severe case, with a minimum mitral valve area 0.8 cm2, regurgitant 227 
volume of 67 mL corresponding to a regurgitant fraction of 54%. Cardiac output decreased 228 
from 5.7 L/min to 4.1 L/min. Resulting LV geometries are shown in Figure 4. LV diastolic wall 229 
thickness decreased from 8.2 mm to 7.8 mm, whereas total LV wall volume increased from 107 230 
mL to 132 mL. The LV enlarged by increasing its diastolic diameter from 54 mm to 62 mm. 231 
The LA also increased its diameter to a similar degree. The results represent a LV eccentric 232 
remodeling pattern.  233 
 
 
Figure 4. Simulation output of different degrees of severity of mitral regurgitation with 
myocardial remodeling.  
 234 
When comparing simulation results with clinical data (Figure 5), it can be seen that they follow 235 
the same direction of changes for LV end-diastolic volume index (EDVI), end-systolic volume 236 
index (ESVI), LV end-systolic diameter (ESD) and LA volume. Also, slopes and offset agreed 237 




Figure 5. Comparison between simulation output in mitral regurgitation and clinical data 




Simulations of aortic regurgitation with adaptive remodeling showed that systolic arterial 241 
pressure was preserved from the normal initial case to the most severe case, with a regurgitant 242 
aortic valve area of 0.45 cm2, regurgitant volume of 83 mL, and regurgitant fraction of 61%. 243 
Diastolic arterial pressure decreased from 76 mmHg to 44 mmHg between the same two 244 
scenarios. Cardiac output decreased from 5.7 L/min to 4.0 L/min. Resulting LV geometries are 245 
shown in the upper row of Figure 6. LV diastolic wall thickness increased from 8.2 mm to 14.7 246 
mm. The LV hypertrophied and enlarged by increasing its wall volume from 108 mL to 305 247 
mL and its diastolic diameter from 54 mm to 65 mm. The LA did not enlarge but became 248 
slightly smaller in the most severe cases. The results represent a LV eccentric remodeling 249 




Figure 6. Simulation output of different degrees of severity of aortic regurgitation with 
complete myocardial remodeling based on both fiber stress and wall shear stress in the upper 
row. The middle row shows adaptation of fiber stress excluding adaptation of wall shear 
stress and the bottom row adaptation of wall shear stress excluding adaptation of fiber stress. 
Wall shear stress induced dilatation and wall thinning occurs in the bottom row, while wall 
volume increase with wall thickening occurs in the middle row with only fiber stress 
adaptation. Both mechanisms are needed for a realistic adaptive remodeling process as seen 
in the upper row. 
 251 
When comparing simulation results with clinical data (Figure 7) for LV EDVI, ESVI, LV ESD 252 
and LV end-diastolic diameter (EDD), all four variables agreed in terms of direction of changes. 253 
Also, LV diastolic and systolic diameters agreed very well in magnitude compared to clinical 254 
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data, whereas LV EDVI and LV ESVI increased less in simulations than in the clinical data as 255 
can be seen in the lower slopes of the simulation regression lines in Figure 7.  256 
 
 
Figure 7. Comparison between simulation output in aortic regurgitation and clinical data from 




The middle and lower rows of Figure 6 show the output of the simulations when the two 260 
adaptation rules were activated separately. σf adaptation alone resulted in an increasing wall 261 
volume. The small changes seen in LV size is caused by the regurgitation contributing to filling 262 
combined with the increased contractility and stiffness associated with increased wall volume. 263 
On the contrary, σwss adaptation alone caused the LV to remodel in an eccentric manner (both 264 
minimum and maximum diameter increased with increasing regurgitant volume), whereas wall 265 
volume remained constant. Notably, despite wall volume not changing, wall thickness 266 
decreased as a consequence of LV enlargement. The combined effect of the two adaptation 267 
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rules in aortic regurgitation are shown in the upper row of Figure 6 and illustrates the 268 
interaction, where σwss induced dilatation results in higher σf and therefore a need for a more 269 




Table 2. – Main hemodynamic variables (simulation output) for the normal case and three 271 























cm2 mmHg mmHg mmHg L/min - - mmHg mmHg 
Baseline 
0/5.00 122 76 95 5.73 0.65 0.65 6.9 4.3 
Mitral regurgitation 
0.3 113 70 86 4.99 0.65 0.65 9.9 4.0 
0.6 104 65 78 4.39 0.65 0.65 12.4 3.7 
0.8 100 63 74 4.11 0.65 0.65 13.7 3.6 
Aortic regurgitation 
0.2 123 60 83 4.82 0.64 0.65 10.7 4.1 
0.3 129 50 77 4.37 0.65 0.65 13.3 3.9 
0.5 131 44 71 3.95 0.65 0.65 16.0 3.9 
Aortic stenosis 
3.00 121.45 76.52 94.67 5.72 0.65 0.65 6.8 4.3 
1.00 115.51 76.11 93.22 5.59 0.65 0.65 8.4 4.2 






The major finding of this study is that our cardiovascular simulation of cardiac remodeling in 276 
valvular disease based purely on mechanical factors accurately predicts typical remodeling 277 
patterns seen in patients. The heart changes its size in conjunction with its myocardial volume 278 
in order to preserve a target σwss and σf  and the resulting geometry is validated against high-279 
resolution MRI imaging (14, 47) (Figures 2, 4 and 6). Simulations show that σf is the main 280 
determinant of hypertrophy (wall volume changes) and σwss the main determinant of LV size 281 
confirming our initial hypothesis. Wall volumes, chamber diameters, wall thickness and end-282 
diastolic compliances are all within an expected range (6, 15, 19). 283 
Cardiac remodeling is a complex, multifactorial process, which is importantly driven by 284 
changes in myocardial loading conditions as a result of e.g. stenotic or regurgitant valves. 285 
Results from this study support the hypothesis that preservation of the clinically accessible 286 
biomechanical factors σf and σwss can explain cardiac remodeling patterns in valvular heart 287 
disease. It should however be mentioned that genetic factors and comorbidities such as 288 
hypertension also play a role and may result in interindividual variation despite similar valve 289 
pathology (37). Our findings are in agreement with a previous simulation study showing that a 290 
model based on passive and active properties of the individual sarcomeres and with mechano-291 
adaptive control could determine chamber size and myocardial wall volume of all four cardiac 292 
chambers in normal physiology (3), but in contrast to this study we use input data extractable 293 
from clinical diagnostic imaging and test the algorithms in a different range of loading 294 
conditions by including valve pathology.  295 
Such simulations models have e.g. been used to explain cardiac chambers size based on fiber 296 
stress (σf) optimization (3), to reproduce wave dynamics throughout the circulation (32), to 297 
explain blood pressure changes with aging (27), to monitor cardiac loading conditions during 298 
mechanical support (7, 13), and could be valuable to differentiate and quantify mechanical 299 
overload-induced cardiac remodeling in individual patients. 300 
While simulation results from this study show how mechanical triggers may be important 301 
factors in cardiac remodeling, they cannot uniquely identify which mechanical variables are the 302 
actual drivers of remodeling. σf and σwss are good candidates given the agreement between 303 
simulations and clinical data. However, other variables such as fiber strain (2) could be 304 
complementary driving factors contributing to remodeling. It is intriguing that when calculating 305 
myofiber shortening (strain) according to Arts et al. (1) (Figure 8) in remodeled AS, it decreases 306 
with stenosis severity in agreement with clinical findings (44) despite preserved ejection 307 
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fraction and increasing LV contractility (end-systolic elastance). The decrease in fiber 308 
shortening (strain) in clinical measurements has been interpreted as a sign of decline in systolic 309 
function (33) but should probably rather be seen as a geometric consequence of wall thickening 310 
in combination with high afterload (44). These clinical and simulation findings speak against 311 
preservation of strain as the principal biomechanical factor determining chamber size, but 312 
deserve further in-depth analysis, to elucidate the precise relation between modeled myofiber 313 
strain on one hand and longitudinal and epi-/endo-cardial circumferential strain as measured 314 
clinically on the other. 315 
 316 
Figure 8. Measures of systolic function in simulated remodeled aortic stenosis. Ejection fraction 317 
(black) is preserved, while elastance (gray) increases with valve stenosis severity. Myofiber 318 
shortening (strain) (dashed black) decreases with valve narrowing and increasing hypertrophy.  319 
 320 
Simulations of the disease process can be seen as a longitudinal study on a single individual as 321 
disease severity progresses. However, clinical data conventionally available like those used for 322 
validation in this study (14, 47) are single time point measurements providing a cross-section 323 
of multiple individuals with different degrees of disease severity. 324 
Simulations of aortic stenosis produced a concentric remodeling pattern with pronounced LV 325 
hypertrophy for the most severe cases (Figure 3). Patient data reported by Dweck et al. (14) 326 
showed many different kinds of LV remodeling patterns in response to aortic stenosis, including 327 
normal LV and LV decompensation. LV decompensation occurs in the late stages of the 328 
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diseases when the myocardium cannot adapt to load changes anymore and therefore the 329 
remodeling rules cannot be met. This structural limit of the myocardium, possibly influenced 330 
both by mechanical material properties and ischemia, has not been included in the modeling 331 
assumption and therefore LV decompensation cannot be predicted with the current model 332 
implementation. The simulation could however predict the other compensatory LV geometries 333 
observed in patients. Firstly, simulations show that aortic maximal area must be small 334 
(< 1.5 cm2) before the LV begins to remodel. This implies that the LV can preserve a normal 335 
geometry down to this aortic valve area. When the adaptive remodeling process starts, it 336 
manifests initially as concentric remodeling and ultimately as concentric hypertrophy (Figure 337 
2). Dweck et al. reported no correlation between aortic area measurements and degree of LV 338 
hypertrophy, which probably is due to a quite narrow range of valve areas (0.93 +/- 0.32 cm2. 339 
Other authors with larger span of aortic valve areas have found a clear relationship with 340 
hypertrophy and found that wall thickness increased proportional to the increase in left 341 
ventricular systolic pressure, preserving wall stress (18). In addition, other individual factors 342 
that influence hypertrophy such as genetic background and additional comorbidities e.g. 343 
hypertension, diabetes and obesity will influence hypertrophy, and this is not taken into account 344 
in the simulations. Finally, non-invasive measurements of effective valve area are prone to 345 
measurement errors, also with MRI. The clear correlation between aortic area and LV mass in 346 
the simulations, occurs mainly for very small aortic areas (<0.75 cm2).  Some of the discordance 347 
between clinical results and simulations can be explained by the difficulty of measuring these 348 
small areas of the stenotic aortic valve using in vivo imaging methods, which have limited 349 
spatial resolution (echocardiography and MRI both >1-2 mm (16)). In addition, the generally 350 
irregular shape of the stenotic aortic valve area might be of hemodynamic importance. Taken 351 
together, the net aortic valve area derived from medical imaging may not be the most robust 352 
measurement of disease severity. 353 
Simulations showed that mitral and aortic regurgitation resulted in an eccentric remodeling 354 
pattern (Figures 4 and 6) in accordance with patient data (47) (Figures 5 and 7). Aortic 355 
regurgitation produced a clear hypertrophy of the LV, whereas mitral regurgitation resulted in 356 
only a mild hypertrophy (Figure 2), due to a progressive decrease in afterload with worsening 357 
regurgitation, since part of the LV output is ejected retrogradely into the low-pressure atrium 358 
instead of into aorta. Simulations also showed that the LA increased its size in mitral 359 
regurgitation but not in aortic regurgitation, where the opposite was seen, that is a slight 360 
decrease in LA size for the most severe cases (Figures 4 and 6). The decrease in LA size in 361 
aortic regurgitation may be explained by a decrease in cardiac output, due to lack of 362 
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autoregulatory control mechanisms preserving systemic flow in our study. The clinical data 363 
reported by Uretsky et al. (47) showed poorer correlation between mitral regurgitant volume 364 
and LV ESVI (r2 = 0.5) and LA volume (r2 = 0.3) than with LV EDVI (r2 = 0.8). The lack of 365 
compensatory baroreflex mediated sympathetic activity in the simulations may explain the 366 
slightly larger simulated end-systolic volumes in mitral regurgitation (Figure 5). Our 367 
simulations showed however that all three variables are clearly correlated to mitral regurgitant 368 
volumes (Figure 5). LV EDVI is the largest of these volumes and it increases the most with 369 
increased regurgitant volume, which makes it an easier and more robust variable to measure. In 370 
the simulation results for mitral regurgitation, it can also be noticed that mild hypertrophy 371 
(defined as an increase in wall volume) does not manifest as an increase in wall thickness, 372 
which slightly decreases due to the LV dilatation. Previous simulation work in aortic 373 
regurgitation has shown how parameters such as ventricular and aortic wall properties can 374 
influence hemodynamic output in a way that is not captured by clinical severity scores (34). 375 
Simulations can highlight the most important factors to take into account and clinically measure 376 
when evaluating a given disease state in general or more specifically the expected remodeling 377 
pattern in an individual patient. As an example, simulations indicate that wall volume or mass-378 
cavity ratio might be alternative indexes of disease severity worthy of clinical evaluation. 379 
 380 
Limitations	381 
Actual σwss and σf values are currently difficult to measure in vivo (see appendix for current σwss 382 
and σf selection criteria). A recent study (29) reports MRI estimated mean σwss in the human left 383 
ventricle in the range 0.2-0.6 Pa corresponding to 0.0015-0.0045 mmHg supporting the target 384 
value 0.0025 mmHg used in the current study. The target value for mean myofiber stress 120 385 
mmHg is supported by Genet et al (17) estimating a normal human operating LV myofiber 386 
stress range of 2.2-16.5 kPa (16.5-124 mmHg) and Lee et al (25) estimating peak LV myofiber 387 
stress to 50-80 kPa (375-600 mmHg) in a group of patients post cardiac surgery due to heart 388 
failure. In the absence of more detailed information, we have applied the same values for all 389 
four chambers. Refined geometrical assumptions and data from future 3D simulation studies 390 
may provide more precise input data that may result in e.g. more realistic atrial sizes. More 391 
specifically, our geometrical assumptions about the RV may need refinement in future studies 392 
concerning right-sided lesions or pulmonary hypertension, since the infundibulum and RV 393 
outlet tract is not taken into consideration in our simplified geometry. The equations relating 394 
wall volumes to chamber volumes assume a geometry with rotational symmetry, which is true 395 
for the atria and left ventricle, but not for the right ventricle. This would also be a significant 396 
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limitation, when applying the model to right-sided lesions or pulmonary hypertension, but does 397 
not affect our conclusions, since right-sided changes are negligible in this study.     398 
 399 
The calculation of σwss was based on the assumption of laminar flow through a tube, which is 400 
an oversimplification of reality. In fact, the LV shows vortical flow patterns (4). In general, 401 
vortexes can be both laminar and/or turbulent and which pattern is seen in ventricular flow is 402 
still under investigation (10, 22). This implies that the calculated σwss might not correspond to 403 
the actual σwss experienced by the chamber walls. However, the target σwss value was chosen in 404 
order to provide physiological hemodynamic output for a normal individual. This simplified 405 
assumption will only affect the magnitude of the simulation output during remodeling, but not 406 
the overall direction of changes. 407 
The present model cannot represent 3D features of the circulatory system. Also, we have 408 
assumed homogenous wall thickness. It is likely that differences in σf and impact of σwss exist 409 
within the myocardial walls. Dweck et al. (14) report both symmetric and asymmetric 410 
remodeling, patterns that cannot be predicted by the type of modeling used in this study 411 
(lumped-parameter 0D modeling), which does not provide local 3D information and therefore 412 
asymmetric remodeling falls into the concentric remodeling and hypertrophy patterns. 413 
However, 0D modeling allows real-time simulation with a standard PC and is therefore a more 414 
realistic clinical decision support tool.  415 
Compensatory mechanisms such as baroreceptor effects and changes in blood volume to 416 
preserve cardiac output were not included in the simulations and neither was vascular 417 
remodeling. These mechanisms may explain some of the differences between simulation results 418 
and clinical data. Future clinical application of the model may have to include the 419 
autoregulatory features of the cardiovascular system.  420 
A crucial clinical question is how to differentiate between adaptive and maladaptive 421 
remodeling. Unfortunately, this question is currently unresolved and also not well understood 422 
in clinical medicine. We can only speculate about ischemia, progressive fibrosis with negative 423 
diastolic and systolic effects and exhaustion of the Starling mechanism driven by changes in 424 
collagen subtypes, oxidative stress, inflammation, neurohormonal activation and mitochondrial 425 
dysfunction (39). Providing “rules” for adaptive remodeling could potentially make it easier to 426 
draw the line between adaptive and maladaptive responses through the course of myocardial 427 
load history. It is likely not possible to fully understand the maladaptive response without a 428 
more detailed simulation of the myocardial sub-cellular structure including vascular supply.   429 
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Sex and ethnic differences have not been taken into account, which is mainly due to lack of 430 
suitable validation studies, but also due to lack of biomechanical hypothesis explaining such 431 
differences. Future studies taking not only these factors, but also body size and comorbidities 432 
are needed to explore these questions. Importantly, this model-based approach allows to 433 
simulate and predict on an individual basis rather than on a group level, which creates an 434 
important future advancement towards patient-specific, individualized cardiovascular 435 
diagnostics and therapeutics. 436 
 437 
Clinical	implications	438 
The importance of remodeling in clinical cardiac disease is indisputable. By being able to 439 
calculate, predict and differentiate the adaptive part of remodeling from other pathological 440 
processes such as ischemia, tissue fatigue and genetic disorders, it may be possible to better 441 
predict what reversibility can be expected after interventions and better differentiate primary 442 
from secondary changes in structural heart disease. Patient-specific simulation of remodeling 443 
may therefore in the future aid in decision-making related to interventions and drug therapy.  444 
 445 
Conclusions	446 
Computer simulations of remodeling show that biomechanical factors alone can explain the 447 
major remodeling patterns (eccentric vs concentric LV hypertrophy) seen in left-sided valvular 448 
heart disease. These findings both qualitatively and quantitatively support the hypothesis that 449 
chamber size and degree of hypertrophy to a large extent can be explained by preservation of 450 
myocardial fiber stress and wall shear stress. Additional clinical and experimental studies in 451 
different pathologies are needed to further validate these results and potentially refine the 452 




Additional information about the model and simulation methods are presented in the following 455 
sections.  456 
Cardiovascular	model	overview	457 
The cardiovascular model used in this study is constituted of multiple lumped-parameter 458 
segments of the circulatory system and has previously been described (8). The four cardiac 459 
chambers are modeled as time-varying elastances, the arterial segments are modeled as 4-460 
element Windkessel models and the cardiac valves change their area gradually during opening 461 
and closing (31). The function of the pericardium to prevent cardiac enlargement and the motion 462 
of the intraventricular septum are also included in the model. The reader is referred to the article 463 
by Broomé et al. (8) for a full description of the model structure and strategies for parameter 464 
selection. Some selected definitions and model equations useful for this specific study are 465 
described below. 466 
Definitions 467 
Variables changing with time are indicated with lower-case letters. Constant parameters are 468 
indicated with upper-case letters.  469 
The time-varying elastance e(t) in each cardiac chamber is defined by the Double-Hill equation 470 
(eq. 1.A): 471 
𝑒(𝑡) = 𝑒;*K(𝑣<L, 𝑞) ∙ 𝑎 ∙ O
P 𝑡𝛼R ∙ 𝑇
T
=U




1 + P 𝑡𝛼3 ∙ 𝑇
T
=VW + 𝑒;F=(𝑣) 1.A 
 472 
ved is the end diastolic volume, q is the flow through the outflow valve of the chamber, t is the 473 
time, T is the time period of one heart cycle, α1, α2, n1 and n2 are dimensionless constants 474 
determining the shape of the elastance curve and thereby the duration of contraction and 475 
relaxation. emin(v) is a variable elastance defining the diastolic pressure-volume relation as 476 
further described in equation 3A.  477 
The value of emax varies in a way that reproduces the Frank-Starling mechanism according to 478 
eq. 2.A: 479 












Where Emax is the systolic contractility constant, Ved,max is the maximum chamber volume 481 
defining the curvature of the end-systolic elastance and Qmax the maximum flow in the 482 
corresponding chamber representing the internal chamber flow resistance (8).  483 
 
𝑒bcd(𝑣) = 𝐸;F= ∙ 𝑒e∙(fgfh) 
 
3.A 
Where Emin is the passive stiffness constant, σ is a constant factor regulating the shape of the 484 
diastolic elastance curve and v0 is the volume at which the end-systolic pressure volume 485 
relationship meet the volume axis in a pressure-volume diagram, representing the unstressed 486 
chamber volume. 487 
Emax and Emin are constant values and are referred to as systolic contractility and passive stiffness 488 
in the main text of this study, respectively. They are input parameters of the model and are not 489 
the same as the end-systolic and end-diastolic elastance. End-systolic and diastolic elastance 490 
can be calculated as pressure/volume at end-systole and end-diastole and are the result of the 491 
complex interaction of Emax, Emin, flows and volumes.  492 
Myocardial	volume	adaptation	493 
An increase in systolic contractility due to remodeling is a result of an increased number of 494 
myocardial fibers or sarcomeres within each fiber. Many fibers and/or sarcomeres imply a 495 
larger myocardial mass. Similarly, a chamber with thicker walls and larger myocardial mass 496 
(excluding the presence of fibrotic tissue) would be a chamber with increased resistance to 497 
myocardial strain (referred to as passive stiffness in the medical literature). Based on the 498 
assumptions that systolic contractility and passive stiffness of each cardiac chamber are directly 499 
proportional to the amount of cardiac muscle present in the chamber wall, the total myocardial 500 
mass was distributed among the four cardiac chambers in proportion to the sum of the passive 501 
stiffness and systolic contractility constant. The origin of this assumption is that in simple 502 
geometries with constant Young’s modulus, a direct relation exists between exerted strain and 503 
material thickness, although many confounding factors such as co-existing fibrosis may 504 
influence the analysis in real patients. The set myocardial volume was then automatically tuned 505 
by the adaptation rules and changed its value from 160 mL to 148 mL, as shown in Table 1 in 506 




During simulation, hemodynamics variables are updated with a frequency of 4 kHz and new 509 
values are based both on the latest parameter changes and the previous simulated values in a 510 
weighted manner, according to the following running mean equation: 511 
𝑥(𝑡 + 1) = 0.999 ∗ 𝑥(𝑡 − 1) + 0.001 ∗ 𝑥(𝑡) 512 
A stable mean value is usually reached within 30-60 seconds after each change of physiological 513 
state of the model, and memory of previous states is therefore lost well in advance of data 514 
harvesting.  515 
Sensitivity	to	wall	shear	stress	and	fiber	stress	516 
The target FS was 120 mmHg and the target WSS was 0.0025 mmHg. These values were 517 
initially chosen of the same order of magnitude as systolic ventricular pressure and measured 518 
myocardial stress (systolic stress of ~ 160,000 dyn/cm2 corresponding to ~ 120 mmHg) (18) 519 
and of measured WSS in large arteries (0.3-1.3 Pa, corresponding to 0.0023-0.0098 mmHg) 520 
(36). The final target values were then tuned to provide physiological hemodynamics as a 521 
starting point for simulations (Table 1A).  522 
We quantitatively assessed the sensitivity of the main hemodynamics variables and LV 523 
properties for an increase and decrease of WSS and FS of 20 % in aortic regurgitation with 524 
valve minimum area equal to 0.3 cm2 corresponding to a regurgitant flow of 66 mL (See Table 525 
1A). The effects of changing target fiber and wall shear stress on left ventricular size and wall 526 
thickness was also explored in the full range of aortic regurgitations as seen in Figure 1A. In 527 
summary, the remodeling adaptation target values had the largest impact on hemodynamics and 528 
ventricular properties in simulations of severe cases of valve disease. Changes in fiber stress 529 
target mainly affects wall thickness/wall volumes, while changes in wall shear stress target 530 
mainly affects chamber diameter/volumes. Our chosen target values are supported both by the 531 
literature, hemodynamic output and the changes in left ventricular properties. 532 
  533 
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Table 1A – Sensitivity of main hemodynamic variables (model output*) to changes in target 534 
























Fiber stress %   
+20%  
(144 mmHg) +1 +3 +4 +6 +4 +5 -1 -4 +1 -18 
-20%  
(96 mmHg) +6 +2 +1 +1 -3 -2 +26 -7 -1 +78 
Wall shear 
stress %   
+20%  
(0.003 mmHg) +6 +5 +6 +9 -5 -23 +10 -2 -8 +5 
-20%  
(0.002 mmHg) -2 -2 -3 -4 +11 +37 +1 -7 +11 +15 
 536 
*Simulations were performed for aortic regurgitation with minimum area equal to 0.3 cm2 (moderate severity). 537 




Figure 1A. Sensitivity analysis showing effects of changing target fiber stress and wall shear 540 
stress on left ventricular wall thickness and size in aortic regurgitation. A range of regurgitant 541 
areas resulting in a regurgitant stroke volume fraction of up to 60% was explored. Changing 542 
the target fiber stress influences wall thickness more than ventricular size as shown in the two 543 
upper panels. The lower panels show that changing target wall shear stress mainly influences 544 
left ventricular size. In general, offsets are more influenced than slopes. Abbreviations: FS; 545 
fiber stress, WSS; wall shear stress.  546 
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Figure 1. (A) Atria. Both the left and right atrium are approximated to be spheres with an inner 710 
radius of r, a wall thickness of h, an inner blood volume of v and a wall volume of vwall. (B) 711 
Left ventricle. The left ventricle is approximated to be a half ellipsoid with max inner radius r, 712 
wall thickness h and a length of 3r. (C) Right ventricle. The right ventricle is approximated to 713 
be a quarter ellipsoid with max inner radius r, wall thickness h and a length of 3r. 714 
 715 
Figure 2. Simulation output of changes in left ventricular end-diastolic volumes and wall 716 
volumes in valvular disease with varying valve areas. Aortic stenosis (AS), mitral regurgitation 717 
(MR) and aortic regurgitation (AR). Valve areas for each simulation step are indicated in the 718 
figure. AS result in concentric hypertrophy and AR and MR in eccentric hypertrophy (more 719 
pronounced hypertrophy in AR). 720 
 721 
Figure 3. Simulation output of different degrees of severity of aortic stenosis with myocardial 722 
remodeling. A small aortic opening area results in a large increase in systolic and diastolic wall 723 
thickness, left ventricular wall volume and a slight decrease in chamber diameter. 724 
 725 
Figure 4. Simulation output of different degrees of severity of mitral regurgitation with 726 
myocardial remodeling. 727 
 728 
Figure 5. Comparison between simulation output in mitral regurgitation and clinical data from 729 
Uretsky et al. (47). The linear regression equations are shown in the lower part of each panel. 730 
 731 
Figure 6. Simulation output of different degrees of severity of aortic regurgitation with complete 732 
myocardial remodeling based on both fiber stress and wall shear stress in the upper row. The 733 
middle row shows adaptation of fiber stress excluding adaptation of wall shear stress and the 734 
bottom row adaptation of wall shear stress excluding adaptation of fiber stress. Wall shear stress 735 
induced dilatation and wall thinning occurs in the bottom row, while wall volume increase with 736 
wall thickening occurs in the middle row with only fiber stress adaptation. Both mechanisms 737 
are needed for a realistic adaptive remodeling process as seen in the upper row. 738 
 739 
Figure 7. Comparison between simulation output in aortic regurgitation and clinical data from 740 
Uretsky et al. (47). The linear regression equations are shown in the lower part of each panel. 741 
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Figure 8. Measures of systolic function in simulated remodeled aortic stenosis. Ejection fraction 742 
(black) is preserved, while elastance (gray) increases with valve stenosis severity. Myofiber 743 
shortening (strain) (dashed black) decreases with valve narrowing and increasing hypertrophy. 744 
 745 
Table 1. Start values representing normal physiology at mean wall shear stress 0.0025 mmHg 746 
and mean myofiber stress 120 mmHg in all chambers. Gray columns show baseline elastance 747 
values and white columns chamber dimensions derived from elastance values using the 748 
geometric assumptions and remodeling algorithms described in the main text. 749 
 750 
Table 2. – Main hemodynamic variables (simulation output) for the normal case and three 751 
different degrees of severity of valve diseases. 752 
 753 
Figure 1A. Sensitivity analysis showing effects of changing target fiber stress and wall shear 754 
stress on left ventricular wall thickness and size in aortic regurgitation. A range of regurgitant 755 
areas resulting in a regurgitant stroke volume fraction of up to 60% was explored. Changing 756 
the target fiber stress influences wall thickness more than ventricular size as shown in the two 757 
upper panels. The lower panels show that changing target wall shear stress mainly influences 758 
left ventricular size. In general, offsets are more influenced than slopes. Abbreviations: FS; 759 
fiber stress, WSS; wall shear stress. 760 
 761 
Table 1A – Sensitivity of main hemodynamic variables (model output*) to changes in target 762 
wall shear stress and fiber stress.  763 
